Objective: Patients receiving cancer treatments commonly experience haematological adverse effects (AEs) related to chemotherapy or molecularly targeted therapies, which may be associated with high ...
More than a million European children undergo CT scans annually. While ionising radiation at moderate to high doses (>100 mGy to >1 Gy) is established as a risk factor for haematological malignancies, ...
Establishing an accurate diagnosis and classification of haematological malignancies (blood cancers) relies on a spectrum of molecular diagnostic tests to evaluate chromosomal and nucleotide changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results